Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Andrew Feldstein: “Credit Derivatives Are Incredible Valuable Tools”

Andrew Feldstein, founder of Blue Mountain Capital, talks about the role of credit derivatives in financial markets on Bloomberg.

Andrew Feldstein said: “I think credit derivatives are incredible valuable tools to the financial markets, and I think the financial markets would be much worse off without them. Like the automobile, the financial instruments can be misused. If you got a drunk driver behind the wheel, or if people don’t obey the rules of the road, or the rules of road are poorly written, valuable tools can be misused and the consequence can be bad.”

Andrew Feldstein and Stephen Siderow

Feldstein left JPMorgan at 2003 because he has a “real entrepreneurial drive to create something and to build something”.

According to Bloomberg, within a year of launching Blue Mountain, Andrew Feldstein and Stephen Siderow expanded the team from 10 to 50, and now they have 120 employees with offices in New York and London. In 2010, Blue Mountain’s credit alternatives fund returned 8.5% to 9.0%, nearly double the industry average. Eighty percent of these gains came from trading individual credit default swap along with collateralized loan obligations.

Feldstein believes the problem in Washington is simple to describe – we have borrowed too much and we made too many promises. The borrower and the entitlement holders of pensions and medical cares have certainly aggravated this trend. But Feldstein said it’s hard to solve the problem.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!